When Loyalty Becomes a Liability: Rethinking Career Strategy in Biopharma
“Loyalty without leverage can be a liability.”
Loyalty is one of those traits that gets celebrated in leadership—until it quietly backfires.
In biopharma especially, loyalty can blur the line between commitment and risk. With layoffs and restructures accelerating across the industry, that tension has never been sharper.
Earlier this month, I explored this in BioSpace—where I write regularly as a columnist on the realities of leadership in biopharma. The article unpacks why loyalty isn’t always the virtue we assume it is, and how leaders (and their teams) can reframe it to protect their careers without losing their sense of purpose.
Here’s the full article, originally published in BioSpace:
👉 When Loyalty Becomes a Liability: Rethinking Career Strategy in Biopharma
Want more like this?
Leadership Insights (Blog)
Hiring from pharma into biotech looks like a low-risk move—but it’s not always a seamless fit. This piece unpacks why even seasoned executives can stall in biotech, and what leadership traits matter more than experience at scale.